Novothelium
UEI: HCF3KC7C19D7
• CAGE: 7HML1
Overview
Awardee Type
Parent
Company Description
NovoThelium is a San Antonio based biotechnology company developing a tissue-engineered matrix for nipple regeneration after mastectomy.
Name
Novothelium
Website
Headquarters
San Antonio, TX
United States
United States
Most Recent Award
Aug. 15, 2024
Calculating
Federal grant recipient
NOVOTHELIUM, LLC
(UEI HCF3KC7C19D7, CAGE 7HML1)
is headquartered in San Antonio TX.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The partnership
was founded in October 2015 and
federally registered in
November 2015.
Federal Award Analysis
Novothelium federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NOVOTHELIUM, LLC
UEI
HCF3KC7C19D7
CAGE Code
7HML1
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Woman Owned Business
Woman Owned Small Business
Woman Owned Business
Woman Owned Small Business
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 20, 2015
Initial Registration
Nov. 24, 2015
Last Registration
July 23, 2025
Registration Activation
July 23, 2025
Registration Expiration
July 18, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
TX
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No